topiramate / Generic mfg.  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

14 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
topiramate / Generic mfg.
NCT00902473: Bioequivalence Study of Topiramate Tablets 25mg Under Fed Conditions

Completed
N/A
18
Canada
Topiramate
Ranbaxy Laboratories Limited
Healthy
09/01
10/01
NCT00901784: Bioequivalence Study of Topiramate Tablets 25mg Under Fasting Conditions

Completed
N/A
28
Canada
Topiramate
Ranbaxy Laboratories Limited
Healthy
09/01
10/01
NCT00304603: Mode of Action of Topiramate in the Treatment of Obese Patients With and Without Type 2 Diabetes Mellitus

Completed
N/A
1145
US
No intervention
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Obesity, Diabetes Mellitus Type 2
04/05
04/05
NCT00297349: A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures

Completed
N/A
153
Europe
Topiramate
Janssen Cilag Pharmaceutica S.A.C.I., Greece
Seizures, Epilepsy
 
06/05
NCT00286923: Does Topiramate Adjust the Excitability of the Brain in Migraine Sufferers?

Unknown status
N/A
10
US
Topiramate
Emerald City Headache Organization, Ortho-McNeil Neurologics, Inc.
Migraine, Chronic Headache
 
08/06
NCT00297336: An Observational Study Evaluating the Safety of Topiramate for the Prevention of Migraine

Completed
N/A
80
Europe
Topiramate
Janssen Cilag Pharmaceutica S.A.C.I., Greece
Migraine Disorders
 
02/07
NCT00297323: An Observational Study of the Safety of Topiramate in Adults and Children With Epilepsy

Completed
N/A
80
Europe
Topiramate
Janssen Cilag Pharmaceutica S.A.C.I., Greece
Seizures, Epileptic
 
02/07
PROMPT-IN, NCT01836874: A Study of Prophylaxis for Migraine Patients With Topiramate in India

Completed
N/A
209
RoW
No intervention
Janssen-Cilag Ltd.
Migraine
07/08
07/08
NCT01030094: A Cross-sectional Study to Investigate the Effect of Topiramate on Bone and Mineral Metabolism in Female Participants With Epilepsy

Completed
N/A
140
RoW
Topiramate, Carbamazepine, Valproic acid, Normal control
Janssen Korea, Ltd., Korea
Seizures, Convulsions, Epilepsy, Osteopenia, Osteoporosis
04/09
04/09
NCT01682681: An Observational Study to Evaluate Long-term Retention Rate of Topiramate in Participants With Epilepsy

Completed
N/A
1234
RoW
Topiramate
Janssen Korea, Ltd., Korea
Epilepsy
05/09
05/09
NCT01390909: Clinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan Database

Completed
N/A
12386
US
Anti-epileptic drug (AED), Mysoline® is a registered trademark of Valeant Pharmaceuticals, Neurotin® is registered trademark of Pfizer, Inc, Vimpat® is a registered trademark of UCB Pharma, Tegretol® is a registered trademark of Novartis Pharmaceuticals, Trileptal® is a registered trademark of Novartis Pharmaceuticals, Sabril® is a registered trademark of Lundbeck Inc, Felbatol® is a registered trademark of MedPointe, Topamax® is a registered trademark of Ortho-McNeill-Janssen Pharmaceuticals, Depakote® is a registered trademark of Abbott Laboratories, Zonegran® is a registered trademark of Dainippon Pharmaceutical C. Ltd., Gabatril® is a registered trademark of Cephalon, Keppra® is registered trademark of UCB Pharma, Zarontin® is a registered trademark of Pfizer, Lamictal® is a registered trademark of GlaxoSmithKline, Luminal® is a registered trademark of Abbott Laboratories, Dilantin® is a registered trademark of Pfizer, Lyrica is registered trademark of Pfizer
GlaxoSmithKline
Epilepsy
01/11
01/11
NCT02098941: Evaluate Retention Rate of Topiramate, Levetiracetam and Oxcarbazepine in a Long-term Epilepsy Treatment

Unknown status
N/A
2500
RoW
Seoul National University Hospital, Janssen Korea, Ltd., Korea
Epilepsy
09/14
12/14
NCT03511118: Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
N/A
1600
Canada, US
Tranexamic acid (TXA), labetalol, metformin, nifedipine, clindamycin, oxycodone, azithromycin, escitalopram, sertraline, ondansetron, Ciprofloxacin, Doxycycline, Levofloxacin, Methylphenidate, Sumatriptan, Citalopram, Cyclobenzaprine, Furosemide, Gabapentin, Hydrochlorothiazide, Hydroxyurea, Rosuvastatin, Topiramate, Trazodone, Valganciclovir, Venlafaxine, Verapamil, Remdesivir, Anakinra, Tocilizumab, Fluvoxamine, Amoxicillin, Bupropion, Duloxetine, Hydrocodone, Levetiracetam, Paroxetine, Buprenorphine
Duke University, The Emmes Company, LLC, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Lactating Women on Select DOI, Breastfed Infants of Mothers on Select DOI
09/24
09/24
TOLERASIT, NCT05209997: Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/Topiramate in Overweight Comorbidities/Obesity

Not yet recruiting
N/A
1500
RoW
Source document data collection
Eurofarma Laboratorios S.A.
Overweight, Obesity
04/25
12/25

Download Options